Solasia Pharma KK
TSE:4597
Income Statement
Earnings Waterfall
Solasia Pharma KK
Revenue
|
617m
JPY
|
Cost of Revenue
|
-280m
JPY
|
Gross Profit
|
337m
JPY
|
Operating Expenses
|
-1.5B
JPY
|
Operating Income
|
-1.1B
JPY
|
Other Expenses
|
27m
JPY
|
Net Income
|
-1.1B
JPY
|
Income Statement
Solasia Pharma KK
Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||
Revenue |
228
N/A
|
226
-1%
|
501
+122%
|
305
-39%
|
306
+0%
|
710
+132%
|
411
-42%
|
414
+1%
|
488
+18%
|
110
-77%
|
318
+188%
|
371
+17%
|
364
-2%
|
498
+37%
|
1 310
+163%
|
1 404
+7%
|
1 419
+1%
|
1 306
-8%
|
454
-65%
|
389
-14%
|
491
+26%
|
449
-9%
|
559
+24%
|
580
+4%
|
470
-19%
|
760
+62%
|
1 092
+44%
|
1 198
+10%
|
1 431
+19%
|
1 209
-16%
|
617
-49%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(71)
|
(71)
|
(213)
|
(207)
|
(161)
|
(189)
|
(65)
|
(108)
|
(110)
|
(117)
|
(209)
|
(206)
|
(300)
|
(265)
|
(185)
|
(173)
|
(89)
|
(159)
|
(430)
|
(490)
|
(607)
|
(568)
|
(280)
|
|
Gross Profit |
0
N/A
|
225
N/A
|
501
+123%
|
304
-39%
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
12
+1 100%
|
38
+217%
|
105
+176%
|
164
+56%
|
203
+24%
|
309
+52%
|
1 245
+303%
|
1 296
+4%
|
1 309
+1%
|
1 189
-9%
|
245
-79%
|
183
-25%
|
191
+4%
|
184
-4%
|
374
+103%
|
407
+9%
|
381
-6%
|
601
+58%
|
662
+10%
|
708
+7%
|
824
+16%
|
641
-22%
|
337
-47%
|
|
Operating Income | ||||||||||||||||||||||||||||||||
Operating Expenses |
(942)
|
(930)
|
(964)
|
(956)
|
(1 067)
|
(1 140)
|
(1 421)
|
(1 500)
|
(1 797)
|
(2 163)
|
(2 525)
|
(2 753)
|
(2 710)
|
(2 776)
|
(3 007)
|
(3 098)
|
(3 329)
|
(3 267)
|
(3 561)
|
(4 406)
|
(4 400)
|
(4 461)
|
(2 793)
|
(2 784)
|
(2 666)
|
(2 908)
|
(3 132)
|
(2 822)
|
(2 527)
|
(1 945)
|
(1 476)
|
|
Selling, General & Administrative |
(434)
|
(436)
|
(488)
|
(510)
|
(558)
|
(629)
|
(647)
|
(701)
|
(826)
|
(886)
|
(1 061)
|
(1 197)
|
(1 274)
|
(1 491)
|
(1 437)
|
(1 948)
|
(1 926)
|
(1 839)
|
(1 182)
|
(2 474)
|
(2 572)
|
(2 714)
|
(1 500)
|
(2 019)
|
(2 091)
|
(2 118)
|
(1 764)
|
(2 024)
|
(1 800)
|
(1 521)
|
(1 073)
|
|
Research & Development |
(508)
|
(494)
|
(475)
|
(446)
|
(509)
|
(512)
|
(774)
|
(798)
|
(970)
|
(1 275)
|
(1 463)
|
(1 554)
|
(1 435)
|
(1 285)
|
(1 138)
|
(1 149)
|
(1 400)
|
(1 423)
|
(1 928)
|
(1 004)
|
(900)
|
(821)
|
(845)
|
(763)
|
(574)
|
(788)
|
(883)
|
(798)
|
(727)
|
(425)
|
(403)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(431)
|
0
|
0
|
0
|
(450)
|
0
|
0
|
0
|
(448)
|
0
|
0
|
0
|
(486)
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(2)
|
(1)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
(3)
|
(5)
|
(1)
|
(928)
|
(928)
|
(926)
|
0
|
(2)
|
(1)
|
(2)
|
1
|
0
|
0
|
1
|
0
|
|
Operating Income |
(714)
N/A
|
(704)
+1%
|
(462)
+34%
|
(651)
-41%
|
(761)
-17%
|
(431)
+43%
|
(1 010)
-134%
|
(1 091)
-8%
|
(1 380)
-26%
|
(2 123)
-54%
|
(2 420)
-14%
|
(2 589)
-7%
|
(2 507)
+3%
|
(2 467)
+2%
|
(1 762)
+29%
|
(1 802)
-2%
|
(2 020)
-12%
|
(2 078)
-3%
|
(3 316)
-60%
|
(4 223)
-27%
|
(4 209)
+0%
|
(4 277)
-2%
|
(2 419)
+43%
|
(2 377)
+2%
|
(2 285)
+4%
|
(2 307)
-1%
|
(2 470)
-7%
|
(2 114)
+14%
|
(1 703)
+19%
|
(1 304)
+23%
|
(1 139)
+13%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||
Interest Income Expense |
(22)
|
(20)
|
(32)
|
(31)
|
(25)
|
(24)
|
(7)
|
(3)
|
(4)
|
(11)
|
(25)
|
(30)
|
(47)
|
(49)
|
(1)
|
(32)
|
(23)
|
(26)
|
(1)
|
(47)
|
(49)
|
(37)
|
(1)
|
(21)
|
(6)
|
(21)
|
(4)
|
(15)
|
(3)
|
4
|
5
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(800)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
2
|
2
|
0
|
2
|
0
|
0
|
(34)
|
0
|
0
|
0
|
(42)
|
0
|
(1)
|
0
|
(22)
|
0
|
0
|
(1)
|
(18)
|
(2)
|
0
|
(2)
|
(1)
|
|
Pre-Tax Income |
(735)
N/A
|
(724)
+2%
|
(495)
+32%
|
(681)
-38%
|
(786)
-15%
|
(455)
+42%
|
(1 016)
-124%
|
(1 094)
-8%
|
(1 383)
-26%
|
(2 133)
-54%
|
(2 445)
-15%
|
(2 617)
-7%
|
(2 554)
+2%
|
(2 516)
+1%
|
(1 797)
+29%
|
(1 834)
-2%
|
(2 043)
-11%
|
(2 104)
-3%
|
(4 159)
-98%
|
(4 272)
-3%
|
(4 259)
+0%
|
(4 314)
-1%
|
(2 442)
+43%
|
(2 397)
+2%
|
(2 290)
+4%
|
(2 329)
-2%
|
(2 492)
-7%
|
(2 131)
+14%
|
(1 708)
+20%
|
(1 302)
+24%
|
(1 135)
+13%
|
|
Net Income | ||||||||||||||||||||||||||||||||
Tax Provision |
54
|
78
|
20
|
28
|
28
|
27
|
9
|
8
|
6
|
5
|
23
|
(43)
|
(43)
|
(44)
|
(70)
|
(4)
|
(4)
|
(27)
|
32
|
21
|
11
|
15
|
(35)
|
(37)
|
(37)
|
(83)
|
(56)
|
(41)
|
(30)
|
33
|
22
|
|
Income from Continuing Operations |
(681)
|
(646)
|
(474)
|
(654)
|
(758)
|
(428)
|
(1 007)
|
(1 086)
|
(1 377)
|
(2 128)
|
(2 422)
|
(2 660)
|
(2 597)
|
(2 560)
|
(1 867)
|
(1 838)
|
(2 047)
|
(2 131)
|
(4 127)
|
(4 251)
|
(4 248)
|
(4 299)
|
(2 477)
|
(2 434)
|
(2 327)
|
(2 412)
|
(2 548)
|
(2 172)
|
(1 738)
|
(1 269)
|
(1 113)
|
|
Net Income (Common) |
(968)
N/A
|
(940)
+3%
|
(762)
+19%
|
(859)
-13%
|
(895)
-4%
|
(493)
+45%
|
(1 007)
-104%
|
(1 086)
-8%
|
(1 377)
-27%
|
(2 128)
-55%
|
(2 422)
-14%
|
(2 661)
-10%
|
(2 599)
+2%
|
(2 561)
+1%
|
(1 867)
+27%
|
(1 838)
+2%
|
(2 045)
-11%
|
(2 131)
-4%
|
(4 127)
-94%
|
(4 251)
-3%
|
(4 249)
+0%
|
(4 300)
-1%
|
(2 478)
+42%
|
(2 436)
+2%
|
(2 330)
+4%
|
(2 415)
-4%
|
(2 548)
-6%
|
(2 173)
+15%
|
(1 737)
+20%
|
(1 267)
+27%
|
(1 112)
+12%
|
|
EPS (Diluted) |
-24.83
N/A
|
-24.1
+3%
|
-18.46
+23%
|
-12.9
+30%
|
-10.3
+20%
|
-5.41
+47%
|
-12.24
-126%
|
-12.35
-1%
|
-15.6
-26%
|
-23.1
-48%
|
-25.98
-12%
|
-25.38
+2%
|
-24.73
+3%
|
-24.36
+1%
|
-17.75
+27%
|
-15.73
+11%
|
-17.56
-12%
|
-18.29
-4%
|
-35.16
-92%
|
-33.82
+4%
|
-32.66
+3%
|
-32.76
0%
|
-19.04
+42%
|
-18.24
+4%
|
-16.15
+11%
|
-14.91
+8%
|
-16.76
-12%
|
-12.93
+23%
|
-10.33
+20%
|
-7.54
+27%
|
-6.61
+12%
|